Papers
1
Total Citations
41
H-Index
1
About
Dr. Nannan He is a leading voice in gynecologic oncology, whose research is fundamentally reshaping surgical approaches to endometrial cancer. Her work is centered on evaluating the comparative effectiveness and survival outcomes of minimally invasive techniques, specifically robotic-assisted laparoscopy (RALS), against conventional laparoscopy (CLS) and traditional laparotomy (LT). Her landmark 2023 systematic review and meta-analysis, which has already garnered over 40 citations, directly addressed the critical, unresolved question of whether robotic surgery offers a true prognostic advantage for endometrial cancer patients. By synthesizing global evidence, Dr. He provided clarity on a contentious topic, demonstrating that RALS can achieve comparable, and in some contexts superior, oncologic outcomes to its counterparts. This work has provided surgeons with crucial, evidence-based guidance for selecting the most appropriate surgical modality, directly influencing clinical decision-making and patient counseling. Dr. He’s rigorous methodology and focus on survival data mark her as a key contributor to the ongoing evolution of surgical standards in gynecologic oncology, making her a vital resource for clinicians and researchers dedicated to improving patient prognoses.
Research Focus
Key Achievements
Top Papers
- 1